Healthcare · Biotechnology
Price
$4.13
Market Cap
$1.3B
Employees
403
Beta
1.11
Avg Volume
5,430,493
CEO
Michael E. Castagna
Business Description
MannKind Corporation operates as a biopharmaceutical firm, primarily focused on innovating and bringing to market respiratory-delivered treatments. Its efforts are directed towards tackling endocrine system disorders and rare lung conditions within the U.S. market. The company's key product is Afrezza, an inhaled insulin designed to improve glycemic control for adults managing diabetes. MannKind also actively markets Thyquidity, promoting it to adult and pediatric endocrinologists and other healthcare professionals for the treatment of hypothyroidism. In terms of collaborations, MannKind holds a strategic licensing and partnership agreement with United Therapeutics Corporation. Furthermore, it is collaborating with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), which is a synthetic variant of human vasoactive intestinal peptide intended to shield cells from inflammatory processes. Established in 1991, MannKind Corporation's corporate offices are located in Westlake Village, California.
Business History
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
API Direct from provider
CALC Derived from statements
P/E Ratio (Price per dollar of earnings)
CALCStock Price / EPS (Diluted)
206.70
Stock Price: $4.13
EPS (Diluted): 0.02
EPS (Diluted): 0.02
P/B Ratio (Price vs net asset value)
APIStock Price / Book Value Per Share
-33.97
Stock Price: $4.13
Total Equity: -$51.02M
Shares: 314,112,000
Total Equity: -$51.02M
Shares: 314,112,000
EV/EBITDA (Total value vs operating profit)
APIEnterprise Value / EBITDA
77.45
Market Cap: $1.28B
Total Debt: $369.60M
Cash: $74.88M
EBITDA: $27.52M
Total Debt: $369.60M
Cash: $74.88M
EBITDA: $27.52M
Enterprise Value (Takeover price (cap + debt - cash))
APIMarket Cap + Total Debt - Cash
$2.1B
Market Cap: $1.28B
Total Debt: $369.60M
Cash: $74.88M
Total Debt: $369.60M
Cash: $74.88M
Gross Margin (Revenue left after direct costs)
APIGross Profit / Revenue
82.5%
Gross Profit: $287.81M
Revenue: $348.97M
Revenue: $348.97M
Operating Margin (Revenue left after all operations)
APIOperating Income / Revenue
11.1%
Operating Income: $38.80M
Revenue: $348.97M
Revenue: $348.97M
Net Margin (Revenue left as actual profit)
APINet Income / Revenue
1.7%
Net Income: $5.86M
Revenue: $348.97M
Revenue: $348.97M
ROE (Profit from shareholder equity)
CALCNet Income / Total Equity
-11.5%
Net Income: $5.86M
Total Equity: -$51.02M
Total Equity: -$51.02M
ROIC (Profit from all invested capital)
CALCNOPAT / Invested Capital
66.3%
Operating Income: $38.80M
Tax Rate: -316.7%
Equity: -$51.02M
Total Debt: $369.60M
Cash: $74.88M
Tax Rate: -316.7%
Equity: -$51.02M
Total Debt: $369.60M
Cash: $74.88M
Current Ratio (Can it pay short-term bills)
APICurrent Assets / Current Liabilities
1.70
Current Assets: $291.58M
Current Liabilities: $171.03M
Current Liabilities: $171.03M
Debt/Equity (Leverage — debt vs equity)
CALCTotal Debt / Total Equity
-7.24
Short-Term Debt: $49.24M
Long-Term Debt: $320.36M
Total Debt: $369.60M
Total Equity: -$51.02M
Long-Term Debt: $320.36M
Total Debt: $369.60M
Total Equity: -$51.02M
Rev/Share (Top-line per share)
CALCRevenue / Shares Outstanding
$1.11
Revenue: $348.97M
Shares: 314,112,000
Shares: 314,112,000
Book Value/Share (Net assets per share)
CALC(Total Assets - Total Liabilities) / Shares
$-0.16
Total Equity: -$51.02M
Shares: 314,112,000
Shares: 314,112,000
FCF/Share (Real cash generated per share)
CALC(Operating Cash Flow + CapEx) / Shares
$0.04
Operating CF: $18.26M
CapEx: -$4.57M
Shares: 314,112,000
CapEx: -$4.57M
Shares: 314,112,000
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
APILast Annual Dividend / Stock Price
0.0%
Last Dividend: N/A
Stock Price: $4.13
Stock Price: $4.13
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
—
Dividends Paid: N/A
Net Income: $5.86M
Net Income: $5.86M
Dividends paid not available in cash flow statement
Industry Benchmarks
Compares MNKD against LLM-researched typical ranges for its
industry. One research call per industry, cached indefinitely — every stock in the same industry
reuses the same baseline.
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
0
Company Classification
— What type of company is this?
1
Industry Landscape
— Where is the industry headed?
2
Company Momentum
— Where is this company trending?
3
Forward Projection
— 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a
DCF Valuation
— Present value of future cash flows
4b
Earnings Power Value
— Floor value — worth with zero growth
4c
Anchored PE
— Industry PE adjusted for growth differential
4d
Reverse DCF
— What growth is the market pricing in?
4e
Revenue-Based DCF
— For growth/narrative companies (skip if mature earner)
4f
Anchored P/S
— Price-to-Sales peer comparison (skip if mature earner)
4g
Scenario Analysis
— Bull / Base / Bear (skip if mature earner)
4h
Dividend Discount Model
— For dividend/income stocks only
4i
Book Value Analysis
— For deep value / turnaround stocks only
4j
Insider Activity
— Are insiders buying or selling?
4f
Cash Flow Quality
— How trustworthy is the FCF?
4g
Debt Maturity Risk
— Can it handle its debt?
4h
Macro Environment
— Rates, market valuation, volatility
4i
Sector Intelligence
— How does this company compare within its sector?
4j
Revenue Confidence
— How reliable is the growth projection?
4k
Sensitivity Analysis
— How fragile is the fair value estimate?
4l
Sector Demand Cycle
— Is the sector in a boom, steady state, or contraction?
5
AI Investigation
— Adaptive research engine (Claude)
5b
Thesis Evaluation
— What does the market believe? (narrative/platform stocks only)
6
Valuation Synthesis
— Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 21, 2026 8:11am (6d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $75.4M | $99.8M | $199.0M | $285.5M | $349.0M |
| Cost of Revenue | $38.9M | $57.5M | $62.8M | $76.6M | $61.2M |
| Gross Profit | $36.6M | $42.3M | $136.2M | $208.9M | $287.8M |
| Operating Expenses | $83.6M | $106.4M | $127.5M | $136.3M | $249.0M |
| Operating Income | -$47.0M | -$64.1M | $8.7M | $72.6M | $38.8M |
| Net Income | -$80.9M | -$87.4M | -$11.9M | $27.6M | $5.9M |
| EBITDA | -$61.1M | -$56.3M | $15.1M | $77.5M | $27.5M |
| EPS | $-0.37 | $-0.44 | $-0.04 | $0.10 | $0.02 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 21, 2026 8:11am (6d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $124.2M | $69.8M | $238.5M | $46.3M | $74.9M |
| Total Current Assets | $219.5M | $234.9M | $373.4M | $268.3M | $291.6M |
| Total Assets | $321.2M | $295.3M | $475.2M | $393.8M | $792.2M |
| Current Liabilities | $48.3M | $67.3M | $104.1M | $81.8M | $171.0M |
| Long-Term Debt | $281.2M | $273.5M | $248.7M | $36.1M | $320.4M |
| Total Liabilities | $530.5M | $545.8M | $721.4M | $472.7M | $843.2M |
| Total Equity | -$209.3M | -$250.5M | -$246.2M | -$78.8M | -$51.0M |
| Retained Earnings | -$3.1B | -$3.2B | -$3.2B | -$3.2B | -$3.2B |
Cash Flow (Annual)
Last updated: Jun 21, 2026 8:11am (6d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$61.7M | -$80.7M | $34.1M | $42.5M | $18.3M |
| Capital Expenditure | -$11.5M | -$7.6M | -$42.4M | -$9.7M | -$4.6M |
| Free Cash Flow | -$73.2M | -$88.3M | -$8.3M | $32.8M | $13.7M |
| Acquisitions (net) | -$56.1M | -$15.3M | $0 | $0 | -$347.7M |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $57.0M | -$54.4M | $168.7M | -$191.4M | $28.6M |
Analyst Estimates (Annual)
Last updated: Jun 26, 2026 11:11am (22h ago)| Metric | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|
| Revenue |
$521.0M $503.0M – $534.2M
|
$536.0M $536.0M – $536.0M
|
$610.7M $573.0M – $643.5M
|
$704.9M $661.3M – $742.7M
|
| EBITDA |
-$98.8M -$101.3M – -$95.4M
|
-$101.7M -$101.7M – -$101.7M
|
-$115.8M -$122.0M – -$108.7M
|
-$133.7M -$140.9M – -$125.4M
|
| Net Income |
$56.8M $14.9M – $97.0M
|
$70.9M -$75.1M – $119.0M
|
$97.8M $90.0M – $104.6M
|
$146.1M $134.3M – $156.3M
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 21, 2026 8:11am (6d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +32.2% | +99.4% | +43.5% | +22.2% |
| Gross Profit Growth | +15.5% | +222.2% | +53.4% | +37.8% |
| Operating Income Growth | -36.3% | +113.5% | +736.4% | -46.5% |
| Net Income Growth | -8.0% | +86.3% | +331.1% | -78.7% |
| EBITDA Growth | +7.8% | +126.9% | +412.0% | -64.5% |
Narrative Economics
The story the market is telling about this stock — the intangible X-factor
(founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond
what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for MNKD — it's generated by the pipeline (
market-narrative step).
No community reviews yet for MNKD.
Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes
personal — only you see this
Sign in to save personal notes and rate your interest in this stock.
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.352 · d1100787 · 2026-06-26 11:39:30